Activation of endogenous neural stem cells for multiple sclerosis therapy

Area of Science:

• Neuroscience
• Immunology
• Regenerative Medicine

Background:

• Multiple sclerosis (MS) is a chronic central nervous system inflammatory disorder causing significant neurological deficits.
• Current immunomodulatory treatments for MS primarily aim to reduce relapse rates but are insufficient for chronic neurological disability.
• Regeneration of MS lesions offers a promising therapeutic avenue for addressing persistent neurological deficits.

Purpose of the Study:

• To review the role of endogenous neural stem cells (NSCs) in the regeneration of multiple sclerosis lesions.
• To highlight the potential of NSC-mediated repair, particularly in the forebrain, for ameliorating cognitive disability in MS.
• To explore strategies enhancing endogenous remyelination via oligodendrocyte progenitor cells or NSCs.

Main Methods:

• Literature review focusing on the regenerative potential of neural stem cells (NSCs) in the context of multiple sclerosis (MS).
• Analysis of therapeutic strategies targeting endogenous remyelination and neuronal regeneration.
• Examination of NSC activation pathways, including parenchymal oligodendrocyte progenitor cells and subventricular zone-derived NSCs.

Main Results:

• Current MS treatments are inadequate for chronic neurological disability.
• Enhancing endogenous remyelination through NSC activation is a key strategy for MS therapy.
• Neuronal regeneration via endogenous NSCs, despite limitations, shows potential for improving cognitive deficits in MS.

Conclusions:

• Regeneration of MS lesions by replacing damaged cells is a critical future therapeutic goal.
• Targeting neural stem cells (NSCs) for remyelination and neuronal regeneration presents a promising approach for MS.
• Further research into NSC-mediated repair, especially in the forebrain, is crucial for managing MS-related cognitive impairment.